SCHEMBL6198593

SCHEMBL6198593

COc1ccc(-c2nc(-c3ccc4c(c3)NC(=O)CC4)cs2)cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.52
▸ RAB9A P51151 4/20 0.52
▸ NPC1 O15118 3/20 0.52
▸ MMP12 P39900 1/20 0.52
▸ POLB P06746 3/20 0.52
▸ ALDH1A1 P00352 8/20 0.51
▸ MEN1 O00255 6/20 0.51
▸ KMT2A Q03164 6/20 0.51
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ MAPK1 P28482 4/20 0.51
▸ KDM4E B2RXH2 5/20 0.50
▸ HTT P42858 2/20 0.50
▸ GAA P10253 2/20 0.48
▸ HPGD P15428 2/20 0.47
▸ TDP1 Q9NUW8 1/20 0.46
▸ CYP1A1 P04798 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP1B1 Q16678 1/20 0.45
▸ PLAU P00749 1/20 0.44
▸ ALOX15 P16050 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6196901 0.92 MAPT (0.64) MAPTRAB9ANPC1MMP12POLB
SCHEMBL8887539 0.86 ALDH1A1 (0.58) MAPTRAB9ANPC1MMP12POLB
SCHEMBL15668432 0.84 ALDH1A1 (0.51) MAPTRAB9ANPC1MMP12POLB
SCHEMBL13224475 0.84 ALOX5 (0.58) MAPTRAB9ANPC1MMP12POLB
SCHEMBL6200730 0.83 MAPT (0.55) MAPTRAB9ANPC1MMP12POLB
SCHEMBL7501066 0.82 MAPT (0.59) MAPTRAB9ANPC1MMP12POLB
SCHEMBL6201584 0.81 POLB (0.78) MAPTRAB9ANPC1POLBALDH1A1
SCHEMBL6200789 0.80 MAPT (0.57) MAPTRAB9ANPC1MMP12POLB
SCHEMBL7705050 0.80 MAPT (0.57) MAPTRAB9ANPC1MMP12POLB
SCHEMBL6198667 0.80 ALDH1A1 (0.72) MAPTRAB9ANPC1POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1130017-B1 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMA CO LTD (JP) 2005-06-15 — — EP disclosed
EP-0934937-B1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMA CO LTD (JP) 2002-02-27 — — EP disclosed
US-RE37556-E1 (ALKOXYPHENYL)THIAZOLE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 — — US disclosed
EP-1130017-A2 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2001-09-05 — — EP disclosed
US-6080764-A PROTECTING VARIOUS TISSUE CELLS FROM DISTURBANCES ASSOCIATED WITH ISCHEMIA AND BLOOD REPERFUSION IN HEART, BRAIN, KIDNEY, LUNG AND DIGESTIVE TRACT BY INHIBITING SUPEROXIDE-RELEASE BY NEUTROPHILIC LEUKOCYTES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-06-27 — — US disclosed
EP-0934937-A1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 — — EP disclosed
US-5677319-A THIAZOLE DERIVATIVE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-10-14 — — US disclosed
US-5643932-A PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 — — US disclosed
EP-0513387-A1 ACTIVE OXYGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-19 — — EP disclosed
Send feedback